We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel SLN Tracer Maps Breast Cancer Metastasis

By MedImaging International staff writers
Posted on 01 Sep 2016
Print article
Image: A sentinel node biopsy for breast cancer diagnosis (Photo courtesy of CancerQuest).
Image: A sentinel node biopsy for breast cancer diagnosis (Photo courtesy of CancerQuest).
A new study describes how a novel sentinel lymph node (SLN) radiotracer helps determine breast cancer spread by targeting a specific antigen.

Researchers at Beijing Cancer Hospital (BJC; Beijing, China) and Peking University Cancer Hospital & Institute (Beijing, China) conducted a retrospective study of 2,317 patients with primary breast cancer who underwent lymphoscintigraphy and sentinel lymph node biopsy (SLNB). Before imaging, all patients were administered a preoperative peritumoral injection of 37 MBq of 99mTc-rituximab, a new SLN radiotracer that binds to the antigen CD20, which is expressed extensively in lymph nodes.

Initial results in 100 randomly selected patients showed that the detection rate for SLN by injection of Tc-99m-rituximab, as verified by lymphoscintigraphy, was 100%. SLNs from the 100 patients were then harvested, guided by a hand-held gamma-detecting probe, and biopsied with a similar success rate of 100%. When examining results of the other 2,217 patients in the study, the detection rate was 98.8% percent for lymphoscintigraphy and 99.9 % for SLN biopsy. The study was published in the August 2016 issue of The Journal of Nuclear Medicine.

“The advantage of Tc-99m-rituximab is its uniform molecular weight and molecular size. It does not escape easily from SLNs to the second echelon lymph nodes,” said senior author Zhi Yang, PhD, chair of the department of nuclear medicine at BJC. “This results in clear SLN imaging in patients and the high success rate of lymphoscintigraphy. In addition, technical factors, such as the injection dose, injection volume and injection site, can be well controlled.”

Lymph nodes serve as biologic filters that contain immune cells to fight infection and clean the blood. When cancer cells break away from a tumor, they can travel through the lymph system; sentinel node surgery allows the surgeon to remove the nodes to determine cancer spread. Since human lymph nodes are only a half-centimeter in size, they are difficult to discern among the surrounding tissue during surgery. Furthermore, even when surgeons are able to map the location of the nodes, there is no current technique that indicates whether or not the lymph nodes contain cancer, requiring removal of more lymph nodes than necessary.

Related Links:
Beijing Cancer Hospital

New
Computed Tomography System
Aquilion ONE / INSIGHT Edition
New
X-ray Diagnostic System
FDX Visionary-A
Radiation Therapy Treatment Software Application
Elekta ONE
Wall Fixtures
MRI SERIES

Print article

Channels

Ultrasound

view channel
Image: The novel method of fighting cancer can stimulate critical cytokine secretion in T cells

Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors

A significant challenge in cancer treatment is the tumor's ability to suppress the immune system, particularly by deactivating T cells that enter the tumor. Once inside, the tumor can inhibit T cells from... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

General/Advanced Imaging

view channel
Image: Automated methods enable the analysis of PET/CT scans (left) to accurately predict tumor location and size (right) (Photo courtesy of Nature Machine Intelligence, 2024. DOI: 10.1038/s42256-024-00912-9)

Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans

Imaging techniques are essential for cancer diagnosis, as accurately determining the location, size, and type of tumors is critical for selecting the appropriate treatment. The key imaging methods include... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.